Lapatinib Induces Autophagy, Apoptosis and Megakaryocytic Differentiation in Chronic Myelogenous Leukemia K562 Cells

Abstract

Lapatinib is an oral, small-molecule, dual tyrosine kinase inhibitor of epidermal growth factor receptors (EGFR, or ErbB/Her) in solid tumors. Little is known about the effect of lapatinib on leukemia. Using human chronic myelogenous leukemia (CML) K562 cells as an experimental model, we found that lapatinib simultaneously induced morphological changes resembling apoptosis, autophagy, and megakaryocytic differentiation. Lapatinib-induced apoptosis was accompanied by a decrease in mitochondrial transmembrane potential and was attenuated by the pancaspase inhibitor z-VAD-fmk, indicating a mitochondria-mediated and caspase-dependent pathway. Lapatinib-induced autophagic cell death was verified by LC3-II conversion, and upregulation of Beclin-1. Further, autophagy inhibitor 3-methyladenine as well as autophagy-related proteins Beclin-1 (ATG6), ATG7, and ATG5 shRNA knockdown rescued the cells from lapatinib-induced growth inhibition. A moderate number of lapatinib-treated K562 cells exhibited features of megakaryocytic differentiation. In summary, lapatinib inhibited viability and induced multiple cellular events including apoptosis, autophagic cell death, and megakaryocytic differentiation in human CML K562 cells. This distinct activity of lapatinib against CML cells suggests potential for lapatinib as a therapeutic agent for treatment of CML. Further validation of lapatinib activity in vivo is warranted.

EGFR inhibitors exacerbate differentiation and cell cycle arrest induced by retinoic acid and vitamin D3in acute myeloid leukemia cells

“…Interestingly, a large panel of TKIs (some of which exert a biological activity overlapping with that of erlotinib) also favored the differentiation of AML cells in the presence of ATRA and/or VD. These encompass alternative EGFR inhibitors (such as lapatinib), 51 as well as imatinib (targeting BCR-ABL, KIT and platelet-derived growth factor receptor, PDGFR) 52 and dasatinib, 53,54 which has a quite distinct inhibitory spectrum 55 including the SFK LYN. 56 The molecular effects of these TKIs remain to be precisely elucidated.…”

Shear enhances thrombopoiesis and formation of microparticles that induce megakaryocytic differentiation of stem cells

“…[26][27][28][29][30] PS exposure is also important in platelet activation. 31 Low level of PS exposure has been also implicated in microparticle formation from different cell types.…”

Key role of phosphodiesterase 4A (PDE4A) in autophagy triggered by yessotoxin

“…This cell line is typically differentiated into megakaryocyte or erythrocyte lineage (Huang et al, 2011;Osti et al, 1997). In this sense, the increment in cAMP levels was related with cellular differentiation in different cellular lines (Copsel et al, 2011;Vassaux et al, 1992).…”